2m 2m 2m 2m 2m 2m 2m
INCANNEX HEAL (IXHL)
NASDAQ
$3.54-$0.03 (-0.98%)
Price as of Aug 24, 2026 9:06 AM EDT- $42.7MMarket Cap
- -79.76%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
INCANNEX HEAL (IXHL)
$3.54-$0.03 (-0.98%)
IXHL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.57 | ||
Change | -$0.05 (-1.38%) | ||
Open | $3.62 | ||
High | $3.65 | ||
Low | $3.51 | ||
Previous Close | $3.62 | ||
Volume | 71,448 | ||
30-Day Average Volume | 90,393 | ||
1-Week Change | 8.84% | ||
1-Month Change | 11.21% | ||
1-Year Change | -79.76% | ||
3-Year Change | -92.09% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 12.0M | ||
Total Assets | $80.3M | ||
Market Cap | $42.7M | ||
Enterprise Value | -$31.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$3.9M | ||
Free Cash Flow | -$2.5M | ||
EBIT | -$3.9M | ||
EBITDA | -$3.8M | ||
Net Working Capital | $78.2M | ||
EPS | -$0.35 | ||
Enterprise Value/EBITDA | 8 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -10 | ||
PEG | 0 | ||
Price/Free Cash Flow | -17 | ||
Price/Operating Cash Flow | -17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 02/27/2026 | ||